Correction to: Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants

Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research